Weiss Michael S

CEO and President, DirectorTG THERAPEUTICS, INC. (TGTX) · full profile →Form 4 · filed Jan 7, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2022Sell(S)31K$18.31$562K11.0M
Jan 4, 2022Sell(S)38K$19.20$721K13.5M
Dec 29, 2021Grant(A)56K$013.5M
Dec 16, 2021Gift(G)9K$013.4M
Dec 16, 2021Gift(G)700K$013.4M
Dec 15, 2021Gift(G)3K$014.1M

Transaction Codes

S
Open-market sale
A
Grant / award
G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-002355) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about TGTX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-22-002355"
Ask your agent
Use Arkolith to summarize insider buying and selling at TG THERAPEUTICS, INC.
over the last 90 days and cite the filings.